204 related articles for article (PubMed ID: 1660142)
1. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.
Scanlon KJ; Jiao L; Funato T; Wang W; Tone T; Rossi JJ; Kashani-Sabet M
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10591-5. PubMed ID: 1660142
[TBL] [Abstract][Full Text] [Related]
2. [Circumventing drug resistance in human tumors by antisense ribozyme].
Funato T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):336-42. PubMed ID: 8109989
[TBL] [Abstract][Full Text] [Related]
3. The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomas.
Funato T; Yoshida E; Jiao L; Tone T; Kashani-Sabet M; Scanlon KJ
Adv Enzyme Regul; 1992; 32():195-209. PubMed ID: 1496917
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated reversal of the multidrug-resistant phenotype.
Scanlon KJ; Ishida H; Kashani-Sabet M
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11123-7. PubMed ID: 7972021
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cells.
Kashani-Sabet M; Wang W; Scanlon KJ
J Biol Chem; 1990 Jul; 265(19):11285-8. PubMed ID: 2113532
[TBL] [Abstract][Full Text] [Related]
6. Reversal of cisplatin resistance in vivo by an anti-fos ribozyme.
Funato T; Ishii T; Kanbe M; Scanlon KJ; Sasaki T
In Vivo; 1997; 11(3):217-20. PubMed ID: 9239514
[TBL] [Abstract][Full Text] [Related]
7. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
Wiechen K; Zimmer C; Dietel M
Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
[TBL] [Abstract][Full Text] [Related]
8. Ribozyme mediated degradation of beta-amyloid peptide precursor mRNA in COS-7 cells.
Denman RB; Smedman M; Ju W; Rubenstein R; Potempska A; Miller DL
Nucleic Acids Res; 1994 Jun; 22(12):2375-82. PubMed ID: 8036167
[TBL] [Abstract][Full Text] [Related]
9. Reversal of the malignant phenotype by an anti-ras ribozyme.
Kashani-Sabet M; Funato T; Tone T; Jiao L; Wang W; Yoshida E; Kashfinn BI; Shitara T; Wu AM; Moreno JG
Antisense Res Dev; 1992; 2(1):3-15. PubMed ID: 1422085
[TBL] [Abstract][Full Text] [Related]
10. Effect of hammerhead ribozyme against human thymidylate synthase on the cytotoxicity of thymidylate synthase inhibitors.
Kobayashi H; Takemura Y; Miyachi H; Skelton L; Jackman AL
Jpn J Cancer Res; 1995 Nov; 86(11):1014-8. PubMed ID: 8567390
[TBL] [Abstract][Full Text] [Related]
11. Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity.
Taverna P; Hansson J; Scanlon KJ; Hill BT
Carcinogenesis; 1994 Sep; 15(9):2053-6. PubMed ID: 7923602
[TBL] [Abstract][Full Text] [Related]
12. Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines.
Tekur S; Ho SM
Mol Carcinog; 2002 Jan; 33(1):44-55. PubMed ID: 11807957
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
Denman RB
Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
[TBL] [Abstract][Full Text] [Related]
14. Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene.
Koizumi M; Kamiya H; Ohtsuka E
Gene; 1992 Aug; 117(2):179-84. PubMed ID: 1639266
[TBL] [Abstract][Full Text] [Related]
15. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
Zhang ZZ; Zhang Q; Wu M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
[TBL] [Abstract][Full Text] [Related]
16. Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme.
Yokoyama Y; Morishita S; Takahashi Y; Hashimoto M; Tamaya T
Br J Cancer; 1997; 76(8):977-82. PubMed ID: 9376277
[TBL] [Abstract][Full Text] [Related]
17. [Circumventing multidrug resistance in human cancer by anti-ribozyme].
Funato T
Nihon Rinsho; 1997 May; 55(5):1116-21. PubMed ID: 9155162
[TBL] [Abstract][Full Text] [Related]
18. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
19. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and molecular properties of cisplatin-resistant A2780 cells grown in folinic acid.
Lu Y; Han J; Scanlon KJ
J Biol Chem; 1988 Apr; 263(10):4891-4. PubMed ID: 3258308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
